CV Sciences (CVSI) Non-Current Assets (2013 - 2026)
CV Sciences (CVSI) posted Non-Current Assets of $1.7 million for Q1 2026, down 5.58% sequentially from $1.8 million in Q4 2025, and down 3.95% YoY from $1.8 million in Q1 2025.
CV Sciences (CVSI) Non-Current Assets (2013 - 2026) Analysis & Trends
CV Sciences has reported Non-Current Assets for 14 years, with the latest figure at $1.7 million in Q1 2026.
- Quarterly Non-Current Assets fell 3.95% year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.5 million (up 1067.83% YoY) and the FY2025 annual result came in at $1.8 million, up 8.61% from the prior year.
- Non-Current Assets declined to $1.7 million in Q1 2026 per CVSI's latest filing, from $1.8 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $3.2 million in Q1 2022 and troughed at -$6.4 million in Q3 2024.
- A 5-year average of $1.4 million and a median of $1.7 million in 2026 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets tumbled 637.05% in 2024, then jumped 129.62% in 2025.
- Over 5 years, Non-Current Assets stood at $1.6 million in 2022, then retreated by 21.42% to $1.3 million in 2023, then jumped by 33.44% to $1.7 million in 2024, then gained by 8.61% to $1.8 million in 2025, then retreated by 5.58% to $1.7 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $1.7 million, $1.8 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.96 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 26.10 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 8.72 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 78.51 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 3.74 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 24.99 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.72 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.76 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 2.96 Bn |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 1.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | -6.41 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.33 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 3.12 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.88 Mn |
| Sep 30, 2021 | 9.40 Mn |